Pages that link to "Q29620650"
Jump to navigation
Jump to search
The following pages link to Hepatitis C virus replication in mice with chimeric human livers (Q29620650):
Displaying 50 items.
- Vaccination for hepatitis C virus: closing in on an evasive target (Q22305922) (← links)
- Human butyrate-induced transcript 1 interacts with hepatitis C virus NS5A and regulates viral replication (Q24305040) (← links)
- Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122 (Q24611792) (← links)
- Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection (Q24628167) (← links)
- MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins (Q24630291) (← links)
- Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity (Q24672232) (← links)
- Single and Multiple Gene Manipulations in Mouse Models of Human Cancer (Q26783920) (← links)
- Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection (Q26784252) (← links)
- Animal models for the study of HCV (Q26797836) (← links)
- Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems (Q26799933) (← links)
- Quantification of viral infection dynamics in animal experiments (Q26824804) (← links)
- New hepatitis C virus drug discovery strategies and model systems (Q26851159) (← links)
- Advances in experimental systems to study hepatitis C virus in vitro and in vivo (Q26851652) (← links)
- Development of humanized mouse models to study human malaria parasite infection (Q26851983) (← links)
- Role of oxidative stress in hepatocarcinogenesis induced by hepatitis C virus (Q26863363) (← links)
- Murine models of hepatitis C: what can we look forward to? (Q26991875) (← links)
- Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections (Q27002381) (← links)
- Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions (Q27002598) (← links)
- T cell responses in hepatitis C virus infection: historical overview and goals for future research (Q27003510) (← links)
- Viruses in cancer cell plasticity: the role of hepatitis C virus in hepatocellular carcinoma (Q27012614) (← links)
- Neutralizing antibody response to hepatitis C virus (Q27027484) (← links)
- Usage of adenovirus expressing thymidine kinase mediated hepatocellular damage for enabling mouse liver repopulation with allogenic or xenogenic hepatocytes (Q27306083) (← links)
- Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach (Q27324340) (← links)
- Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages (Q27329614) (← links)
- Targeted induction of interferon-λ in humanized chimeric mouse liver abrogates hepatotropic virus infection (Q27333253) (← links)
- Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance (Q27469038) (← links)
- The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding (Q27472668) (← links)
- Cell clones selected from the Huh7 human hepatoma cell line support efficient replication of a subgenomic GB virus B replicon (Q27472890) (← links)
- The phantom menace (Q27472943) (← links)
- Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients (Q27473046) (← links)
- The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity (Q27473081) (← links)
- Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs (Q27473092) (← links)
- SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells (Q27473129) (← links)
- Host-Specific Response to HCV Infection in the Chimeric SCID-beige/Alb-uPA Mouse Model: Role of the Innate Antiviral Immune Response (Q27473258) (← links)
- Application of functional genomics to the chimeric mouse model of HCV infection: optimization of microarray protocols and genomics analysis (Q27473268) (← links)
- A milestone for hepatitis C virus research: A virus generated in cell culture is fully viable in vivo (Q27473434) (← links)
- Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro (Q27473436) (← links)
- Novel Robust Hepatitis C Virus Mouse Efficacy Model (Q27477521) (← links)
- Viruses and human cancer (Q27481175) (← links)
- Cell Culture Adaptation of Hepatitis C Virus and In Vivo Viability of an Adapted Variant (Q27485033) (← links)
- Hepatitis C Virus Genotype 1a Growth and Induction of Autophagy (Q27485449) (← links)
- Mouse models for the study of HCV infection and virus–host interactions (Q27486807) (← links)
- Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens (Q27487009) (← links)
- Role of the Hepatitis C Virus Core+1 Open Reading Frame and Core cis-Acting RNA Elements in Viral RNA Translation and Replication (Q27487337) (← links)
- HCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID/Alb-uPA Mice (Q27487963) (← links)
- Using high-throughput genomics to study hepatitis C: What determines the outcome of infection? (Q27488407) (← links)
- Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma (Q27488744) (← links)
- Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence (Q27488844) (← links)
- Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C (Q27488958) (← links)
- Adoptive immunotherapy with liver allograft–derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice (Q27490263) (← links)